Niklason Laura E 13D and 13G filings for Humacyte, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-20 7:10 pm Sale | 2024-11-18 | 13D | Humacyte, Inc. HUMA | Niklason Laura E | 6,007,745 4.600% | -1,697,728 (-22.03%) | Filing |
| 2024-09-03 4:11 pm Sale | 2024-08-29 | 13D | Humacyte, Inc. HUMA | Niklason Laura E | 7,705,473 6.300% | -1,481,428 (-16.13%) | Filing |
| 2024-06-04 7:00 pm Sale | 2024-05-31 | 13D | Humacyte, Inc. HUMA | Niklason Laura E | 9,186,901 7.600% | -966,294 (-9.52%) | Filing |
| 2024-03-08 4:03 pm Purchase | 2024-03-05 | 13D | Humacyte, Inc. HUMA | Niklason Laura E | 10,153,195 8.400% | 102,373 (+1.02%) | Filing |
| 2023-09-15 4:09 pm Sale | 2023-09-14 | 13D | Humacyte, Inc. HUMA | Niklason Laura E | 10,050,822 9.500% | -1,561,987 (-13.45%) | Filing |
| 2023-08-21 6:19 pm Sale | 2023-08-17 | 13D | Humacyte, Inc. HUMA | Niklason Laura E | 11,612,809 11.100% | -7,173,402 (-38.18%) | Filing |
| 2023-05-26 5:05 pm Sale | 2023-05-25 | 13D | Humacyte, Inc. HUMA | Niklason Laura E | 18,786,211 17.900% | -4,482,068 (-19.26%) | Filing |
| 2021-08-27 9:14 pm Purchase | 2021-08-26 | 13D | Humacyte, Inc. HUMA | Niklason Laura E | 23,268,279 22.400% | 23,268,279 (New Position) | Filing |